221 related articles for article (PubMed ID: 20512947)
21. Review article: colorectal cancer surveillance in ulcerative colitis - what should we be doing?
Obrador A; Ginard D; Barranco L
Aliment Pharmacol Ther; 2006 Oct; 24 Suppl 3():56-63. PubMed ID: 16961747
[TBL] [Abstract][Full Text] [Related]
22. Tumor necrosis factor-alpha polymorphisms in ulcerative colitis-associated colorectal cancer.
Garrity-Park MM; Loftus EV; Bryant SC; Sandborn WJ; Smyrk TC
Am J Gastroenterol; 2008 Feb; 103(2):407-15. PubMed ID: 18289203
[TBL] [Abstract][Full Text] [Related]
23. Molecular profiling of ulcerative colitis-associated neoplastic progression.
Colliver DW; Crawford NP; Eichenberger MR; Zacharius W; Petras RE; Stromberg AJ; Galandiuk S
Exp Mol Pathol; 2006 Feb; 80(1):1-10. PubMed ID: 16277983
[TBL] [Abstract][Full Text] [Related]
24. The risk for cancer or dysplasia in ulcerative colitis patients with primary sclerosing cholangitis.
Shetty K; Rybicki L; Brzezinski A; Carey WD; Lashner BA
Am J Gastroenterol; 1999 Jun; 94(6):1643-9. PubMed ID: 10364038
[TBL] [Abstract][Full Text] [Related]
25. [The pathogenesis of ulcerative colitis-associated colorectal cancer].
Sipos J
Magy Onkol; 2004; 48(1):35-43. PubMed ID: 15105894
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic problems and advances in inflammatory bowel disease.
Odze R
Mod Pathol; 2003 Apr; 16(4):347-58. PubMed ID: 12692200
[TBL] [Abstract][Full Text] [Related]
27. Is dysplasia visible during surveillance colonoscopy in patients with ulcerative colitis?
Blonski W; Kundu R; Lewis J; Aberra F; Osterman M; Lichtenstein GR
Scand J Gastroenterol; 2008; 43(6):698-703. PubMed ID: 18569987
[TBL] [Abstract][Full Text] [Related]
28. Earlier surveillance colonoscopy programme improves survival in patients with ulcerative colitis associated colorectal cancer: results of a 23-year surveillance programme in the Japanese population.
Hata K; Watanabe T; Kazama S; Suzuki K; Shinozaki M; Yokoyama T; Matsuda K; Muto T; Nagawa H
Br J Cancer; 2003 Oct; 89(7):1232-6. PubMed ID: 14520452
[TBL] [Abstract][Full Text] [Related]
29. Prediction of colorectal neoplasia by quantitative methylation analysis of estrogen receptor gene in nonneoplastic epithelium from patients with ulcerative colitis.
Tominaga K; Fujii S; Mukawa K; Fujita M; Ichikawa K; Tomita S; Imai Y; Kanke K; Ono Y; Terano A; Hiraishi H; Fujimori T
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8880-5. PubMed ID: 16361578
[TBL] [Abstract][Full Text] [Related]
30. Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation.
Itzkowitz SH; Yio X
Am J Physiol Gastrointest Liver Physiol; 2004 Jul; 287(1):G7-17. PubMed ID: 15194558
[TBL] [Abstract][Full Text] [Related]
31. Predicting ulcerative colitis-associated colorectal cancer using reverse-transcription polymerase chain reaction analysis.
Watanabe T; Kobunai T; Yamamoto Y; Ikeuchi H; Matsuda K; Ishihara S; Nozawa K; Iinuma H; Kanazawa T; Tanaka T; Yokoyama T; Konishi T; Eshima K; Ajioka Y; Hibi T; Watanabe M; Muto T; Nagawa H
Clin Colorectal Cancer; 2011 Jun; 10(2):134-41. PubMed ID: 21859567
[TBL] [Abstract][Full Text] [Related]
32. Aberrant methylation of the HPP1 gene in ulcerative colitis-associated colorectal carcinoma.
Sato F; Shibata D; Harpaz N; Xu Y; Yin J; Mori Y; Wang S; Olaru A; Deacu E; Selaru FM; Kimos MC; Hytiroglou P; Young J; Leggett B; Gazdar AF; Toyooka S; Abraham JM; Meltzer SJ
Cancer Res; 2002 Dec; 62(23):6820-2. PubMed ID: 12460892
[TBL] [Abstract][Full Text] [Related]
33. Characterization of genomic instability in ulcerative colitis neoplasia leads to discovery of putative tumor suppressor regions.
Chen R; Bronner MP; Crispin DA; Rabinovitch PS; Brentnall TA
Cancer Genet Cytogenet; 2005 Oct; 162(2):99-106. PubMed ID: 16213356
[TBL] [Abstract][Full Text] [Related]
34. Ulcerative colitis-associated colorectal cancer.
Yashiro M
World J Gastroenterol; 2014 Nov; 20(44):16389-97. PubMed ID: 25469007
[TBL] [Abstract][Full Text] [Related]
35. [Molecular carcinogenesis in ulcerative colitis-associated and sporadic colorectal carcinoma--differences and similarities].
Aust DE; Baretton GB; Waldman FM; Löhrs U
Verh Dtsch Ges Pathol; 1999; 83():130-8. PubMed ID: 10714203
[TBL] [Abstract][Full Text] [Related]
36. Ulcerative colitis and colon cancer.
Isbell G; Levin B
Gastroenterol Clin North Am; 1988 Dec; 17(4):773-91. PubMed ID: 3068141
[TBL] [Abstract][Full Text] [Related]
37. Studies in longstanding ulcerative colitis with special reference to malignant transformation of the colorectal mucosa.
Löfberg R
Acta Chir Scand Suppl; 1989; 552():1-45. PubMed ID: 2800882
[TBL] [Abstract][Full Text] [Related]
38. Characterization of tumour-infiltrating lymphocytes and apoptosis in colitis-associated neoplasia: comparison with sporadic colorectal cancer.
Michael-Robinson JM; Pandeya N; Walsh MD; Biemer-Huttmann AE; Eri RD; Buttenshaw RL; Lincoln D; Clouston AD; Jass JR; Radford-Smith GL
J Pathol; 2006 Feb; 208(3):381-7. PubMed ID: 16315333
[TBL] [Abstract][Full Text] [Related]
39. Limits of diagnosis and molecular markers for early detection of ulcerative colitis-associated colorectal neoplasia.
Fujii S; Katsumata D; Fujimori T
Digestion; 2008; 77 Suppl 1():2-12. PubMed ID: 18204256
[TBL] [Abstract][Full Text] [Related]
40. Rectal sparing and skip lesions in ulcerative colitis: a comparative study of endoscopic and histologic findings in patients who underwent proctocolectomy.
Joo M; Odze RD
Am J Surg Pathol; 2010 May; 34(5):689-96. PubMed ID: 20410806
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
